Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, Reinhart K, Falsey AR, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Oliveira CF, Maravić-Stojković V, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen JS, Corti C, van Oers JAH, Beishuizen A, Girbes ARJ, de Jong E, Briel M, Mueller B. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018 Jan;18(1):95-107. \[[PubMed: 29037960](https://pubmed.ncbi.nlm.nih.gov/29037960)\] 24. Williamson HA. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract. 1987 Sep;25(3):251-6. \[[PubMed: 3625141](https://pubmed.ncbi.nlm.nih.gov/3625141)\] 25. Smucny J, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001726. \[[PubMed: 17054140](https://pubmed.ncbi.nlm.nih.gov/17054140)\] 26. Becker LA, Hom J, Villasis-Keever M, van der Wouden JC. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev. 2015 Sep 03;2015(9):CD001726. \[[PMC free article: PMC7078572](/pmc/articles/PMC7078572/)\] \[[PubMed: 26333656](https://pubmed.ncbi.nlm.nih.gov/26333656)\] 27. Smith DRM, Dolk FCK, Pouwels KB, Christie M, Robotham JV, Smieszek T. Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care. J Antimicrob Chemother. 2018 Feb 01;73(suppl_2):ii11-ii18. \[[PMC free article: PMC5890733](/pmc/articles/PMC5890733/)\] \[[PubMed: 29490061](https://pubmed.ncbi.nlm.nih.gov/29490061)\] 28. Llor C, Bjerrum L. Antibiotic prescribing for acute bronchitis. Expert Rev Anti Infect Ther. 2016 Jul;14(7):633-42. \[[PubMed: 27219826](https://pubmed.ncbi.nlm.nih.gov/27219826)\] 29. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000245. \[[PubMed: 15494994](https://pubmed.ncbi.nlm.nih.gov/15494994)\] 30. Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Baniecki M, Hendrick VM, Damle B, Simón-Campos A, Pypstra R, Rusnak JM., EPIC-HR Investigators. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med. 2022 Apr 14;386(15):1397-1408. \[[PMC free article: PMC8908851](/pmc/articles/PMC8908851/)\] \[[PubMed: 35172054](https://pubmed.ncbi.nlm.nih.gov/35172054)\] 31. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 18, 2023. Features, Evaluation, and Treatment of Coronavirus (COVID-19) \[[PubMed: 32150360](https://pubmed.ncbi.nlm.nih.gov/32150360)\] 32. Wesolowski A, Miller JL, Shields M, Dela-Pena J. Antimicrobial prescribing after rapid influenza PCR implementation in the emergency department. Am J Emerg Med. 2023 Sep;71:123-128. \[[PubMed: 37390608](https://pubmed.ncbi.nlm.nih.gov/37390608)\] 33. Tejada S, Jansson M, Solé-Lleonart C, Rello J. Neuraminidase inhibitors are effective and safe in reducing influenza complications: meta-analysis of randomized controlled trials. Eur J Intern Med. 2021 Apr;86:54-65. \[[PubMed: 33358065](https://pubmed.ncbi.nlm.nih.gov/33358065)\] 34. Ivaska L, Barkoff AM, Mertsola J, He Q. Macrolide Resistance in _Bordetella pertussis_ : Current Situation and Future Challenges. Antibiotics (Basel). 2022